RxDoctor Payments Data

Brooke Kirk

Family · Princeton, WVNPI 1376208702

Payments from drug & device makers

$4,756in general payments, 2019–2025

Across 290 payments — averaging $16.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$889
  • Novo Nordisk$498
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$459
  • Kowa Pharmaceuticals America, Inc.$407
  • Boehringer Ingelheim$378
  • Amgen$369
  • plus $2K from 18 others

What the payments were for

  • Food & beverage$4,756100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,756 in reported general payments places this provider in the 90th percentile of 1,507 family providers in West Virginia.

See all family providers in West Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide39$62,076
JardianceEmpagliflozin36$45,042
FarxigaDapagliflozin Propanediol30$43,190
EliquisApixaban28$39,344
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$27,320
TrulicityDulaglutide21$24,898
TradjentaLinagliptin12$12,168
VascepaIcosapent Ethyl11$11,399
Novolog FlexpenInsulin Aspart11$3,164
Lantus SolostarInsulin Glargine,hum.Rec.Anlog20$3,146
Gabapentin167$2,166
Albuterol Sulfate HfaAlbuterol Sulfate32$1,642
Rosuvastatin Calcium83$1,300
Levothyroxine Sodium125$1,193
Famotidine90$1,189

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$498$62,07639 claims
Boehringer IngelheimJardiance, Tradjenta$378$57,21048 claims
AstraZenecaFarxiga$889$43,19030 claims
PfizerEliquis$33$39,34428 claims
GSKTrelegy Ellipta$350$27,32019 claims
Lilly USA, LLCTrulicity$298$24,89821 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,507 family providers in West Virginia.

Other family in Princeton

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →